$1.51 0.00 (0.00%) Infinity Pharmaceuticals Inc - NASDAQ

Sep. 29, 2016 | 04:00 PM
Last Trade: 1.51
Trade Time: Sep 29 04:00 PM Eastern Daylight Time
Change: +0.00 (0.00%)
Prev Close: 1.51
Open: 1.58
Bid: 1.49
Ask: 1.75
  1. No results found.
  1. Mid-Afternoon Market Update: Crude Oil Slides Over 2%; MannKind Shares Dip On Termination Of Afrezza Deal With Sanofi

    Benzinga | Jan. 5, 2016 | 15:07PM EST
  2. Infinity Announces Enrollment Of 120th Patient In Phase 2 DYNAMO™ Study Evaluating Duvelisib In Indolent Non-Hodgkin Lymphoma

    Benzinga | Sep. 30, 2015 | 09:03AM EST
  3. A Portfolio To Support Cancer Treatments In Time For Prostate Cancer Awareness Month

    Benzinga | Sep. 8, 2015 | 16:05PM EST
  4. Benzinga's Top Initiations

    Benzinga | May. 7, 2015 | 10:03AM EST
  5. It's A Big Weekend For Biotech

    Benzinga | Apr. 17, 2015 | 16:31PM EST
  6. JPM Securities Picks Through Biotech News For Winners

    Benzinga | Feb. 25, 2015 | 12:41PM EST
  7. UPDATE: Infinity Pharmaceuticals Posts Q4 Loss

    Benzinga | Feb. 24, 2015 | 17:41PM EST
  8. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  9. Morning Market Losers

    Benzinga | Jan. 8, 2015 | 09:54AM EST
  10. Pharmaceuticals, Therapeutics And A Retailer On The Move Thursday Morning

    Benzinga | Jan. 8, 2015 | 09:00AM EST
  11. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 8, 2015 | 08:22AM EST
  12. Infinity Announces Clinical And Preclincal Data For Duvelisib To Be Presented at ASH 2014 Annual Meeting

    Benzinga | Nov. 6, 2014 | 09:06AM EST
  13. Infinity Reports Topline Data From Phase 2a Exploratory Study Of Duvelisib In Patients With Mild, Allergic Asthma

    Benzinga | Oct. 16, 2014 | 07:35AM EST
  14. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga | Sep. 22, 2014 | 12:59PM EST
  15. Pharmacyclics Price Target Cut On Higher Spending

    IBD | Sep. 8, 2014 | 13:02PM EST
Trading Center